116 related articles for article (PubMed ID: 8537316)
1. Morphology of ras-transformed cells becomes apparently normal again with tyrosine kinase inhibitors without a decrease in the ras-GTP complex.
Kwon HJ; Yoshida M; Muroya K; Hattori S; Nishida E; Fukui Y; Beppu T; Horinouchi S
J Biochem; 1995 Jul; 118(1):221-8. PubMed ID: 8537316
[TBL] [Abstract][Full Text] [Related]
2. Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells.
Mandanas RA; Leibowitz DS; Gharehbaghi K; Tauchi T; Burgess GS; Miyazawa K; Jayaram HN; Boswell HS
Blood; 1993 Sep; 82(6):1838-47. PubMed ID: 7691239
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of anchorage-independent growth affect the growth of transformed cells on poly(2-hydroxyethyl methacrylate)-coated surfaces.
Fukazawa H; Nakano S; Mizuno S; Uehara Y
Int J Cancer; 1996 Sep; 67(6):876-82. PubMed ID: 8824562
[TBL] [Abstract][Full Text] [Related]
4. Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS.
Auvinen M; Paasinen-Sohns A; Hirai H; Andersson LC; Hölttä E
Mol Cell Biol; 1995 Dec; 15(12):6513-25. PubMed ID: 8524216
[TBL] [Abstract][Full Text] [Related]
5. Suppression of morphological transformation by radicicol is accompanied by enhanced gelsolin expression.
Kwon HJ; Yoshida M; Nagaoka R; Obinata T; Beppu T; Horinouchi S
Oncogene; 1997 Nov; 15(21):2625-31. PubMed ID: 9399650
[TBL] [Abstract][Full Text] [Related]
6. Radicicol inhibits tyrosine phosphorylation of the mitotic Src substrate Sam68 and retards subsequent exit from mitosis of Src-transformed cells.
Pillay I; Nakano H; Sharma SV
Cell Growth Differ; 1996 Nov; 7(11):1487-99. PubMed ID: 8930398
[TBL] [Abstract][Full Text] [Related]
7. v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells.
Masumoto N; Nakano S; Fujishima H; Kohno K; Niho Y
Int J Cancer; 1999 Mar; 80(5):731-7. PubMed ID: 10048975
[TBL] [Abstract][Full Text] [Related]
8. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
Clark JW; Santos-Moore A; Stevenson LE; Frackelton AR
Int J Cancer; 1996 Jan; 65(2):186-91. PubMed ID: 8567115
[TBL] [Abstract][Full Text] [Related]
9. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Ras signaling pathway by the CD40 receptor.
Gulbins E; Brenner B; Schlottmann K; Koppenhoefer U; Linderkamp O; Coggeshall KM; Lang F
J Immunol; 1996 Oct; 157(7):2844-50. PubMed ID: 8816388
[TBL] [Abstract][Full Text] [Related]
11. Identification of radicicol as an inhibitor of in vivo Ras/Raf interaction with the yeast two-hybrid screening system.
Ki SW; Kasahara K; Kwon HJ; Eishima J; Takesako K; Cooper JA; Yoshida M; Horinouchi S
J Antibiot (Tokyo); 1998 Oct; 51(10):936-44. PubMed ID: 9917007
[TBL] [Abstract][Full Text] [Related]
12. Radicicol binds and inhibits mammalian ATP citrate lyase.
Ki SW; Ishigami K; Kitahara T; Kasahara K; Yoshida M; Horinouchi S
J Biol Chem; 2000 Dec; 275(50):39231-6. PubMed ID: 11007781
[TBL] [Abstract][Full Text] [Related]
13. Transient activation of Ras-dependent signalling at the early stages of Herbimycin A induced erythroid differentiation of human K562 cells.
Drobot L; Husak Z; Ilnytska O; Igumentseva N; Oleksyn H; Kusen' S
Exp Oncol; 2005 Mar; 27(1):31-7. PubMed ID: 15812354
[TBL] [Abstract][Full Text] [Related]
14. Selective apoptosis of tandemly duplicated FLT3-transformed leukemia cells by Hsp90 inhibitors.
Minami Y; Kiyoi H; Yamamoto Y; Yamamoto K; Ueda R; Saito H; Naoe T
Leukemia; 2002 Aug; 16(8):1535-40. PubMed ID: 12145695
[TBL] [Abstract][Full Text] [Related]
15. Induction of hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes.
Murakami Y; Uehara Y; Yamamoto C; Fukazawa H; Mizuno S
Exp Cell Res; 1991 Aug; 195(2):338-44. PubMed ID: 2070817
[TBL] [Abstract][Full Text] [Related]
16. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
[TBL] [Abstract][Full Text] [Related]
17. [Morphological reversion of tumor cells by histone deacetylase inhibitors and radicicol].
Yoshida M; Honda A; Horinouchi S
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1512-8. PubMed ID: 9309149
[TBL] [Abstract][Full Text] [Related]
18. Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells.
Izquierdo M; Downward J; Graves JD; Cantrell DA
Mol Cell Biol; 1992 Jul; 12(7):3305-12. PubMed ID: 1620132
[TBL] [Abstract][Full Text] [Related]
19. Activation of Ras and formation of GAP complex during TPA-induced monocytic differentiation of HL-60 cells.
Katagiri K; Hattori S; Nakamura S; Yamamoto T; Yoshida T; Katagiri T
Blood; 1994 Sep; 84(6):1780-9. PubMed ID: 7521689
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A.
Uehara Y; Murakami Y; Mizuno S; Kawai S
Virology; 1988 May; 164(1):294-8. PubMed ID: 2452516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
